Skip to main content
Equibles
TNGX logo

TNGX · Tango Therapeutics, Inc.

Track TNGX — free

Use TNGX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about TNGX

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$25.60 -0.05 (-0.19%) At close · Aug 14
Market Cap
$4.32B
Shares
168.61M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.

Funds holding TNGX

181 fund positions
Fund Balance Value % of Fund Open
VANGUARD TOTAL STOCK MARKET INDEX FUND 3,931,487 $82,246,708 0.00%
iShares Russell 2000 ETF 2,713,594 $56,768,386 0.08%
Fidelity Growth Company Fund 2,472,200 $54,338,956 0.06%
Select Biotechnology Portfolio 2,339,362 $51,419,177 0.98%
State Street(R) SPDR(R) S&P(R) Biotech ETF 1,972,571 $41,266,185 0.56%
Fidelity Small Cap Index Fund 1,098,223 $23,743,581 0.07%
VANGUARD EXTENDED MARKET INDEX FUND 1,094,475 $22,896,417 0.03%
iShares Russell 2000 Value ETF 952,742 $19,931,363 0.16%
Fidelity Series Growth Company Fund 672,000 $14,770,560 0.06%
iShares Biotechnology ETF 687,885 $14,390,554 0.18%
Fidelity Growth Company K6 Fund 618,856 $13,602,455 0.05%
T. Rowe Price Health Sciences Fund, Inc. 638,486 $13,357,127 0.12%
VANGUARD RUSSELL 2000 INDEX FUND 570,473 $12,538,997 0.07%
Fidelity Small Cap Growth Fund 535,000 $11,566,700 0.14%
Fidelity Extended Market Index Fund 508,440 $11,175,511 0.03%
Schwab U.S. Small-Cap ETF 471,380 $10,360,932 0.05%
Franklin Biotechnology Discovery Fund 447,635 $9,677,869 0.93%
Fidelity Advisor Biotechnology Fund 403,626 $8,726,394 0.46%
State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF 315,077 $6,591,411 0.28%
First Trust Small Cap Growth AlphaDEX Fund 278,656 $6,024,543 0.58%
Fidelity Small Cap Growth K6 Fund 271,300 $5,865,506 0.14%
iShares Micro-Cap ETF 279,924 $5,856,010 0.48%
Invesco Dorsey Wright SmallCap Momentum ETF 249,204 $5,477,504 1.31%
Schwab Small-Cap Index Fund 243,661 $5,267,951 0.07%
Fidelity Series Small Cap Core Fund 210,500 $4,551,010 0.28%
JNL Multi-Manager Small Cap Value Fund 210,740 $4,408,681 0.26%
Fidelity Total Market Index Fund 186,895 $4,107,952 0.00%
U.S. SMALL CAP PORTFOLIO 171,167 $3,700,631 0.02%
Master Small Cap Index Series 174,475 $3,650,017 0.08%
First Trust Small Cap Core AlphaDEX Fund 165,931 $3,587,428 0.30%
Invesco Dorsey Wright Healthcare Momentum ETF 159,490 $3,448,174 2.85%
U.S. MICRO CAP PORTFOLIO 153,967 $3,328,767 0.04%
Fidelity Series Total Market Index Fund 149,357 $3,282,867 0.00%
VANGUARD U.S. MOMENTUM FACTOR ETF 146,692 $3,224,290 0.18%
LVIP State Street Small-Cap Index Fund 96,900 $3,029,094 0.13%
VANGUARD HEALTH CARE INDEX FUND 133,599 $2,936,506 0.02%
Nuveen Small Cap Blend Index Fund 133,048 $2,876,498 0.07%
Fidelity Small Cap Value Index Fund 137,453 $2,875,517 0.16%
iShares Core S&P Total U.S. Stock Market ETF 126,775 $2,652,133 0.00%
College Retirement Equities Fund - Total Global Stock Account 126,182 $2,639,727 0.00%
Direxion Daily S&P Biotech Bull 3X Shares 112,975 $2,442,520 0.47%
EQ/2000 Managed Volatility Portfolio 114,233 $2,389,754 0.07%
Invesco RAFI US 1500 Small-Mid ETF 96,029 $2,076,147 0.07%
VANGUARD RUSSELL 2000 VALUE INDEX FUND 87,518 $1,923,646 0.15%
Fidelity Nasdaq Composite Index Fund 86,354 $1,898,061 0.01%
Nuveen Equity Index Fund 84,735 $1,831,971 0.00%
Strategic Advisers Fidelity U.S. Total Stock Fund 80,800 $1,775,984 0.00%
NORTH SQUARE DYNAMIC SMALL CAP FUND 79,720 $1,752,246 0.22%
EQ/Small Company Index Portfolio 71,630 $1,498,500 0.09%
VANGUARD BALANCED INDEX FUND 69,634 $1,456,743 0.00%
Showing 1–50 of 181 positions
Key facts CIK 1819133 CUSIP 87583X109 13F (30d) 245 filings 241 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)